ReviewNanoscale advances2026
Recent advances in Ti
Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrocatalysis is central to the development of sustainable energy conversion technologies and environmental remediation systems, yet the rational design of high-performance, cost-effective, and durable electrocatalysts remains a fundamental challenge. In recent years, MXenes, a rapidly expanding family of two-dimensional transition-metal carbides, nitrides, and carbonitrides, have emerged as a transformative class of materials owing to their metallic conductivity, tunable surface chemistry, rich termination groups, and structural versatility. These unique attributes endow MXenes with exceptional potential for a wide spectrum of electrocatalytic reactions, including the hydrogen evolution reaction, oxygen evolution reaction, and CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.